Cite
APA Citation
Gardner, L. A., Klawitter, J., Gregory, M. A., Zaberezhnyy, V., Baturin, D., Pollyea, D. A., Takebe, N., Christians, U., Gore, L., DeGregori, J., & Porter, C. C. (n.d.). inhibition of calcineurin combined with dasatinib has direct and indirect anti‐leukemia effects against BCR‐ABL1+ leukemia. American journal of hematology, 89(9), 896–903. http://access.bl.uk/ark:/81055/vdc_100024899433.0x000030